Ingrid Kromann is Director of Vaccine Development Department; Center for Vaccine Research at Statens Serum Institut Ingrid Kromann has more than 20 years’ experience working in the field of Vaccine development she is currently responsible for the overall vaccine development covering activities from product process development to clinical development. During the last 15 years, three different TB vaccines, two novel liposomal adjuvant formulations, a Chlamydia vaccine and a new TB skin test have been developed and tested in humans. Ingrid Kromann is involved in several international research consortiums covering both process development and clinical development.
Conference Session Materials
This section has yet to be updated by the speaker.